Direct Transfer of Mesoporous Silica Nanoparticles between Macrophages and Cancer Cells.
cancer
doxorubicin
intercellular transport
macrophage
mesoporous silica nanoparticle
tunneling nanotubes
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Oct 2020
09 Oct 2020
Historique:
received:
15
09
2020
revised:
04
10
2020
accepted:
06
10
2020
entrez:
14
10
2020
pubmed:
15
10
2020
medline:
15
10
2020
Statut:
epublish
Résumé
Macrophages line the walls of microvasculature, extending processes into the blood flow to capture foreign invaders, including nano-scale materials. Using mesoporous silica nanoparticles (MSNs) as a model nano-scale system, we show the interplay between macrophages and MSNs from initial uptake to intercellular trafficking to neighboring cells along microtubules. The nature of cytoplasmic bridges between cells and their role in the cell-to-cell transfer of nano-scale materials is examined, as is the ability of macrophages to function as carriers of nanomaterials to cancer cells. Both direct administration of nanoparticles and adoptive transfer of nanoparticle-loaded splenocytes in mice resulted in abundant localization of nanomaterials within macrophages 24 h post-injection, predominately in the liver. While heterotypic, trans-species nanomaterial transfer from murine macrophages to human HeLa cervical cancer cells or A549 lung cancer cells was robust, transfer to syngeneic 4T1 breast cancer cells was not detected in vitro or in vivo. Cellular connections and nanomaterial transfer in vivo were rich among immune cells, facilitating coordinated immune responses.
Identifiants
pubmed: 33050177
pii: cancers12102892
doi: 10.3390/cancers12102892
pmc: PMC7600949
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : NCI 2P30 CA118100
Pays : United States
Références
Histochem J. 2002 May;34(5):189-213
pubmed: 12587997
Sci Rep. 2019 Oct 10;9(1):14529
pubmed: 31601865
Oncotarget. 2017 Mar 28;8(13):20939-20960
pubmed: 28423494
J Cell Sci. 2005 Aug 15;118(Pt 16):3695-703
pubmed: 16046474
J Immunol. 2004 Aug 1;173(3):1511-3
pubmed: 15265877
Nanomedicine (Lond). 2013 Feb;8(2):239-52
pubmed: 22891864
Anticancer Res. 2009 Jan;29(1):343-7
pubmed: 19331171
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):260-76
pubmed: 20166114
Cancers (Basel). 2020 Apr 01;12(4):
pubmed: 32244839
Biomaterials. 2009 May;30(13):2440-8
pubmed: 19215978
Results Probl Cell Differ. 2017;62:161-179
pubmed: 28455709
Cell Death Differ. 2011 Apr;18(4):732-42
pubmed: 21113142
Eur J Immunol. 2011 Sep;41(9):2472-6
pubmed: 21952799
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
Front Immunol. 2018 Oct 26;9:2472
pubmed: 30416504
Small. 2016 Apr 13;12(14):1882-90
pubmed: 26854197
Sci Rep. 2018 Jun 21;8(1):9484
pubmed: 29930346
Cold Spring Harb Perspect Med. 2013 Aug 01;3(8):
pubmed: 23906882
ACS Nano. 2018 Aug 28;12(8):8423-8435
pubmed: 30016073
Small. 2012 Oct 22;8(20):3151-60
pubmed: 22930522
Curr Top Microbiol Immunol. 2004;282:117-63
pubmed: 14594216
J Alzheimers Dis. 2014;40 Suppl 1:S37-45
pubmed: 24595196
Sci Rep. 2017 Aug 17;7(1):8547
pubmed: 28819224
Nanomedicine (Lond). 2014 Apr;9(5):581-592
pubmed: 23731456
Nanoscale. 2010 Aug;2(8):1512-20
pubmed: 20820744
Adv Mater. 2018 Dec;30(50):e1805557
pubmed: 30368972
Small. 2011 Jun 6;7(11):1526-32
pubmed: 21520497
Nature. 2015 Dec 3;528(7580):93-8
pubmed: 26536111
Nano Today. 2015 Aug;10(4):487-510
pubmed: 26640510
Nanoscale. 2015 Jul 14;7(26):11444-52
pubmed: 26083979
Chemistry. 2015 Sep 28;21(40):13850-65
pubmed: 26250991
Chemistry. 2016 Jul 4;22(28):9624-30
pubmed: 27258427
Sci Rep. 2016 Dec 23;6:39632
pubmed: 28008977
Expert Opin Drug Deliv. 2011 Apr;8(4):415-33
pubmed: 21348773
J Immunol. 2002 Dec 1;169(11):6162-9
pubmed: 12444120
J Immunol. 2001 Mar 15;166(6):3645-9
pubmed: 11238601
Nat Cell Biol. 2009 Mar;11(3):328-36
pubmed: 19198598
Sci Rep. 2017 Jan 06;7:40360
pubmed: 28059146
Cells. 2019 Jun 21;8(6):
pubmed: 31234435
Curr Opin Cell Biol. 2017 Aug;47:1-8
pubmed: 28231489
Immunology. 1986 Aug;58(4):665-9
pubmed: 3733156
Mech Dev. 2013 Jun-Aug;130(6-8):381-7
pubmed: 23246917
Immunity. 2005 Sep;23(3):309-18
pubmed: 16169503
Nanomedicine (Lond). 2009 Dec;4(8):903-17
pubmed: 19958227
FEBS Lett. 2007 May 22;581(11):2194-201
pubmed: 17433307
J Control Release. 2015 Apr 28;204:11-9
pubmed: 25646783
Nat Mater. 2014 Feb;13(2):125-38
pubmed: 24452356
Int J Biochem Cell Biol. 2016 Feb;71:44-54
pubmed: 26704468
J Immunol. 2014 Aug 1;193(3):1184-93
pubmed: 24981452
Science. 2007 Feb 16;315(5814):992-5
pubmed: 17303755
J Cell Sci. 2012 Mar 1;125(Pt 5):1089-98
pubmed: 22399801
ACS Nano. 2019 Feb 26;13(2):1078-1096
pubmed: 30608136
Nanomedicine (Lond). 2014 Apr;9(5):695-707
pubmed: 24827844
Cell Death Dis. 2016 Dec 22;7(12):e2523
pubmed: 28005071
Biomed Res Int. 2020 Apr 13;2020:2701345
pubmed: 32351987
J Biol Chem. 2002 Dec 6;277(49):47671-8
pubmed: 12359724
Nat Rev Mol Cell Biol. 2008 Jun;9(6):446-54
pubmed: 18464790
Cell Death Differ. 2015 Jul;22(7):1181-91
pubmed: 25571977
J Immunol. 2006 Dec 15;177(12):8476-83
pubmed: 17142745
Cancer Rep (Hoboken). 2019 Dec;2(6):e1213
pubmed: 32467880